Don't Bridge Patients Most Afib Patients With Enoxaparin

August 2015

You'll see LESS use of "bridging" with low-molecular-weight heparin (enoxaparin, etc) in warfarin patients.

Up to 1 in 6 patients are bridged when warfarin is temporarily stopped before a procedure...hoping to prevent thrombosis or stroke.

But evidence from the new BRIDGE trial will be a game changer. It suggests that bridging does more harm than good in many patients.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote